KALV logo

KALV

KalVista Pharmaceuticals, Inc.NASDAQHealthcare
$19.90+0.66%ClosedMarket Cap: $1.02B

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

18

Sales

28

Buy/Sell Ratio

0.64

Total Bought

$0.00

Total Sold

$15.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri Mar 27Venrock Healthcare Capital Partners III, L.P.10 percent ownerSell160$17.535,129,340
Fri Mar 27Venrock Healthcare Capital Partners III, L.P.10 percent ownerSell174,485$16.955,129,500
Fri Mar 27Venrock Healthcare Capital Partners III, L.P.10 percent ownerSell3,183$19.125,089,354
Fri Mar 27Venrock Healthcare Capital Partners III, L.P.10 percent ownerSell15,417$18.825,092,537
Fri Mar 27Venrock Healthcare Capital Partners III, L.P.10 percent ownerSell21,386$17.765,107,954
Tue Mar 10Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICERSell15,625$0.00458,508
Tue Mar 10Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICERSell6,693$16.08451,815
Tue Feb 24Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICERSell10,034$15.57442,883
Tue Feb 24Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICERSell23,250$0.00452,917
Tue Feb 24Audhya Paul K.officer: CHIEF MEDICAL OFFICERSell5,354$15.57138,983
Tue Feb 24Audhya Paul K.officer: CHIEF MEDICAL OFFICERSell6,250$0.00139,337
Tue Feb 24Audhya Paul K.officer: CHIEF MEDICAL OFFICERSell5,000$0.00144,337